dr tyna moore tirzepatide Moore, ND, DC Dr. Tyna Moore (@DrTynaMoore) -

It helps boost energy, improve hydration, enhance immunity, and support overall health and wellness

Tirzepatide tends to be the better choice if: You have a higher starting BMI (say, above 35) and want maximum weight loss You also have type 2 diabetes and need stronger glycemic control You've tried semaglutide and plateaued before reaching your goal Cost is similar for you (LillyDirect direct-pay vials currently undercut Wegovy on entry tiers) Semaglutide tends to be the better choice if: You have established cardiovascular disease and want a drug with proven CV outcome benefit (SELECT) [9] You tolerated 1 mg Ozempic well in the past and your insurance covers Wegovy You prefer the longer real-world track record (Wegovy approved 2021 versus Zepbound 2023) You need an oral option (Rybelsus, though it's FDA-approved for diabetes, not weight loss) Either is reasonable if: You're starting from BMI 30 to 35 with no major comorbidities Your insurance pushes you toward one over the other You're in the early titration period and haven't yet seen what your response looks like A real-world example

It also has an impact on inflammation throughout the body, which could be beneficial for individuals suffering from conditions like arthritis, inflammatory bowel disease (IBD), and even cardiovascular disease

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews